Business Context and Reporting Period
Company: Marchex, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2014
Event: Entry into a Material Definitive Agreement (Underwriting Agreement) for a public offering of Class B common stock.
Key Financial Metrics and Offering Details
- Offering Price: $10.50 per share.
- Total Shares Sold (Firm Shares): 5,714,000 shares.
- Share Allocation: 2,857,000 shares sold by Marchex; 2,857,000 shares sold by Selling Stockholders.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 857,100 additional shares (514,100 from Marchex; 343,000 from Selling Stockholders).
- Net Proceeds to Company: Approximately $27.2 million (after underwriting discounts, commissions, and estimated expenses; excludes proceeds to Selling Stockholders).
- Use of Proceeds: General corporate purposes, including potential acquisitions, licenses, or investments in products, services, technologies, or businesses.
Note: This filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics for the company.
Material Changes and Agreements
- Underwriting Agreement: Entered into with Deutsche Bank Securities Inc. as representatives of the underwriters.
- Lock-Up Agreements: Directors and executive officers entered into 90-day lock-up agreements; Selling Stockholders entered into 180-day lock-up agreements.
- Indemnification: Marchex and Selling Stockholders agreed to indemnify underwriters against certain liabilities.
- Closing Date: Scheduled to occur on or about April 1, 2014.
Guidance, Outlook, and Risks
Management Commentary: The company intends to utilize net proceeds for general corporate purposes, specifically highlighting potential strategic acquisitions or investments.
Risks and Contingencies: The filing notes customary representations, warranties, covenants, and closing conditions within the Underwriting Agreement. The press release regarding the pricing is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the final closing date of the offering (scheduled for approx. April 1, 2014).
- Confirm whether the underwriters' 30-day over-allotment option is exercised.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific closing conditions and indemnification details.
- Monitor subsequent filings for the actual use of the $27.2 million in net proceeds.
- Check for any changes in the company's capital structure resulting from the issuance of new shares.